![](https://monteverdelaw.com/wp-content/uploads/case-logo/vascular-biogenics-ltd.png)
Vascular Biogenics Ltd. (NASDAQ: VBLT), relating to its proposed merger with Notable Labs, Inc. Under the terms of the agreement, VBLT shareholders are expected to own approximately 24% of the combined company.
Vascular Biogenics Ltd. (NASDAQ: VBLT), relating to its proposed merger with Notable Labs, Inc. Under the terms of the agreement, VBLT shareholders are expected to own approximately 24% of the combined company.